头颈部癌症治疗过程中有无自适应容积旋转调强放疗时适形指数与均匀性指数一致性的评估
本研究纳入55例晚期头颈部癌症患者,均接受同步整合推量容积旋转调强放疗,将初始计划投射至新CT并制作2个自适应计划,比较初始计划、混合计划与自适应计划的适形指数和均匀性指数。结果显示体重和肿瘤体积显著下降,混合计划中危及器官剂量显著增加,适形指数和均匀性指数在混合计划中退步、在自适应计划中改善;作者结论为体重下降等解剖变化大幅影响计划质量,自适应计划可维持适形指数和均匀性指数。
要点
- 55例晚期头颈部癌症患者接受同步整合推量容积旋转调强放疗,初始计划投射至新CT并制作2个自适应计划。
- CT1至CT3体重和肿瘤体积显著下降,双侧腮腺体积在10次和20次分次后显著减少。
- 混合计划中脑干等危及器官剂量显著增加,适形指数和均匀性指数在混合计划中退步、在自适应计划中改善。
核心结论
- 作者结论为体重下降等解剖变化大幅影响计划质量,自适应计划通过维持适形指数和均匀性指数与初始计划一致而保持了计划质量。
研究设计与样本
- 55例晚期头颈部癌症患者接受同步整合推量容积旋转调强放疗,初始计划投射至新CT,每例在新CT上制作2个自适应计划,比较初始计划、混合计划与自适应计划的适形指数和均匀性指数。
主要发现
- CT1、CT2、CT3之间体重显著下降(P < .001),CT1中位体重75.78(68.95-83.42)kg,CT2为74.88(68.35-82.2)kg,CT3为73.1(67.6-80.7)kg。
- 肿瘤体积在CT1、CT2、CT3显著下降,初始肿瘤体积32.3(21-58.6)cc,CT2为28.24(15.85-48.63)cc,CT3为25.12(14.1-42.2)cc。
- 左侧腮腺体积在10次和20次分次后显著下降,CT1中位体积31.04(26.34-36.27)cc,10次分次后25.84(19.19-28.59)cc,20次分次后19.5(13.53-22.25)cc。
- 右侧腮腺体积CT1中位29.81(24.6-38.75)cc,CT2为22.38(18.19-30.12)cc,CT3降至17.74(13.41-22.66)cc。
- 混合计划中危及器官剂量显著增加,脑干中位剂量初始计划为5156(4561-5324)cGy,混合计划1增至5321(4688-5545)cGy,混合计划2再增至5401(4821-5812)cGy。
关键数值与推荐
- 适形指数在混合计划1和混合计划2中退步,在自适应计划1和自适应计划2中改善。
- 均匀性指数在混合计划中退步,在自适应计划中改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Conformity indices (CI) and homogeneity indices (HI) are important tools for evaluating treatment plan quality. In this study, we evaluate the consistency of these indices with respect to anatomic changes undergone by patients. METHODS AND MATERIALS: Fifty-five patients with advanced head and neck cancer were treated with simultaneous integrated boost volumetric modulated arc therapy. The initial plan (iplan) then was projected on the new computed tomographs (CT) and 2 adaptive plans (Aplans) for each patient were performed on the new CTs. A comparison of CI and HI between the iplan, hybrid plan (Hplan), and Aplan was performed. RESULTS: There was a significant weight loss (P < .001) between CT1, CT2, and CT3, where the median weight at CT1 was 75.78 (68.95-83.42) kg, and 74.88 (68.35-82.2) kg at CT2 and 73.1 (67.6-80.7) kg at CT3. Also, gross tumor volume (GTV) showed significant decrease at CT1, CT2, and CT3. The initial GTV was 32.3 (21-58.6) cc and 28.24 (15.85-48.63) cc at CT2 and 25.12 (14.1-42.2) at CT3. In addition, there was a significant decrease in left parotid volume after 10 and 20 fractions; the median left parotid gland volume at CT1 was 31.04 (26.34-36.27) cc, then was 25.84 (19.19-28.59) cc after 10 fractions and 19.5 (13.53-22.25) cc after 20 fractions; the median right parotid volume at CT1 was 29.81 (24.6-38.75) cc and 22.38 (18.19-30.12) cc at CT2, then the volume fell to 17.74 (13.41-22.66) cc at CT3. Also, a significant increase in dose to organs at risk were noticed at Hplans, the median dose for brain stem at iplan was 5156 (4561-5324) cGy then increased to 5321 (4688-5545) cGy at Hplan1 then increased again to reach 5401 (4821-5812) cGy at Hplan2. The CI showed regression at Hplan1 and Hplan2 and then improvement at Aplan1 and Aplan2. The HI also showed regression in its value at the Hplans and then improved at the Aplans. CONCLUSIONS: Based on the results, we conclude that anatomic changes such as weight loss greatly affect the quality of plan, and with Aplans, we maintained the quality of plan by sustaining the values of CI and HI as in the iplan.
引用
- Al-Rawi SAI, Abouelenein H, Khalil MM, et al. Evaluation of Conformity and Homogeneity Indices Consistency Throughout the Course of Head and Neck Cancer Treatment With and Without Using Adaptive Volumetric Modulated Arc Radiation Therapy. Adv Radiat Oncol. 2022. PMID: 35465630. doi:10.1016/j.adro.2022.100905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。